Symbol: |
SH3PXD2A
|
Description: |
SH3 and PX domains 2A [Source:HGNC Symbol;Acc:23664]
|
Location: |
Chr10:105348285-105615301[-]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:181
Gene |
Compound |
Gen_sig |
Exp_pattern |
SH3PXD2A |
NSC 106723 |
0.027 |
Up |
SH3PXD2A |
NSC 112789 |
0.035 |
Down |
SH3PXD2A |
NSC 116878 |
0.006 |
Up |
SH3PXD2A |
D-Amethopterin |
0.027 |
Up |
SH3PXD2A |
NSC 11865 |
0.001 |
Up |
SH3PXD2A |
NSC 119911 |
0.038 |
Up |
SH3PXD2A |
Ethanesulfonic acid, compd. with 4-[3-[p-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)benzyl]ureido]-o-toluenesulfonyl fluoride (1:1) |
0.006 |
Up |
SH3PXD2A |
Cyclo-C |
0.042 |
Up |
SH3PXD2A |
Ethanesulfonic acid, compd. with 2-(2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenoxy)acetanilide (1:1) |
0.026 |
Up |
SH3PXD2A |
Ethanesulfonic acid, compd. with 4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)-m-hydrocinnamotoluidide (1:1) |
0.005 |
Up |
SH3PXD2A |
NSC 142506 |
0.019 |
Down |
SH3PXD2A |
as-Triazine-3,5(2H,4H)-dione, 2-.beta.-D-ribofuranosyl-3-thio- |
0.035 |
Up |
SH3PXD2A |
NSC 147358 |
0.037 |
Up |
SH3PXD2A |
Bromocriptine methanesulfonate |
0.025 |
Up |
SH3PXD2A |
7H-Pyrrolo[2,3-d]pyrimidine-5-carbonitrile, 4-amino-6-hydrazino-7-.beta.-D-ribofuranosyl- |
0.003 |
Up |
Expression pattern: Sensitivity / Resistance
Total:13 Current:1
[First] [Prev]  Next Last 
|
SNP:
~ Export ~
|
Records:136
Total:10 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:4
Gene |
Gen_transcript |
miRNA |
miR_location |
SH3PXD2A |
ENST00000315994 |
hsa-mir-208a |
Chr14:23857811-23857832[-] |
SH3PXD2A |
ENST00000315994 |
hsa-mir-208b |
Chr14:23887206-23887227[-] |
SH3PXD2A |
ENST00000369774 |
hsa-mir-208b |
Chr14:23887206-23887227[-] |
SH3PXD2A |
ENST00000315994 |
hsa-mir-429 |
Chr1:1104435-1104456[+] |
Total:1 Current:1
[First] [Prev] [Next] [Last]
|